{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T13:03:42Z","timestamp":1768741422828,"version":"3.49.0"},"reference-count":22,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The differential diagnosis of myeloid malignancies is challenging and subject to interobserver variability. We used clinical and next-generation sequencing (NGS) data to develop a machine learning model for the diagnosis of myeloid malignancies independent of bone marrow biopsy data based on a 3-institution, international cohort of patients. The model achieves high performance, with model interpretations indicating that it relies on factors similar to those used by clinicians. In addition, we describe associations between NGS findings and clinically important phenotypes and introduce the use of machine learning algorithms to elucidate clinicogenomic relationships.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004755","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T09:16:43Z","timestamp":1633079803000},"page":"4361-4369","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["A geno-clinical decision model for the diagnosis of myelodysplastic syndromes"],"prefix":"10.1182","volume":"5","author":[{"given":"Nathan","family":"Radakovich","sequence":"first","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"},{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manja","family":"Meggendorfer","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1460-1611","authenticated-orcid":false,"given":"Luca","family":"Malcovati","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1363-7452","authenticated-orcid":false,"given":"C. Beau","family":"Hilton","sequence":"additional","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"},{"name":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkael A.","family":"Sekeres","sequence":"additional","affiliation":[{"name":"Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Shreve","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cleveland Clinic, Cleveland, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-3225","authenticated-orcid":false,"given":"Yazan","family":"Rouphail","sequence":"additional","affiliation":[{"name":"College of Arts and Sciences, The Ohio State University, Columbus, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-9838","authenticated-orcid":false,"given":"Wencke","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Hutter","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-3756","authenticated-orcid":false,"given":"Anna","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Pozzi","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Elena","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Padron","sequence":"additional","affiliation":[{"name":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3763-5504","authenticated-orcid":false,"given":"Michael R.","family":"Savona","sequence":"additional","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Pediatrics, Program in Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3422-1309","authenticated-orcid":false,"given":"Aaron T.","family":"Gerds","sequence":"additional","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudipto","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1876-5269","authenticated-orcid":false,"given":"Rami S.","family":"Komrokji","sequence":"additional","affiliation":[{"name":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7660-5255","authenticated-orcid":false,"given":"Babal K.","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Bavaria, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Nazha","sequence":"additional","affiliation":[{"name":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"20","key":"2021110519402073200_B1","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"1","key":"2021110519402073200_B2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00277-012-1565-4","article-title":"Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification","volume":"92","author":"Font","year":"2013","journal-title":"Ann Hematol."},{"key":"2021110519402073200_B3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.leukres.2018.04.003","article-title":"Inter-observer variance and the need for standardization in the morphological classification of myelodysplastic syndrome","volume":"69","author":"Sasada","year":"2018","journal-title":"Leuk Res."},{"issue":"5","key":"2021110519402073200_B4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11899-017-0405-y","article-title":"Nuances of morphology in myelodysplastic diseases in the age of molecular diagnostics","volume":"12","author":"Shaver","year":"2017","journal-title":"Curr Hematol Malig Rep."},{"issue":"1","key":"2021110519402073200_B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood."},{"issue":"43","key":"2021110519402073200_B6","doi-asserted-by":"crossref","first-page":"73483","DOI":"10.18632\/oncotarget.19008","article-title":"Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions","volume":"8","author":"Valent","year":"2017","journal-title":"Oncotarget."},{"issue":"5","key":"2021110519402073200_B7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11899-017-0407-9","article-title":"Molecular data and the IPSS-R: how mutational burden can affect prognostication in MDS","volume":"12","author":"Nazha","year":"2017","journal-title":"Curr Hematol Malig Rep."},{"issue":"12","key":"2021110519402073200_B8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.leukres.2012.08.009","article-title":"Molecular genetics in myelodysplastic syndromes","volume":"36","author":"Haferlach","year":"2012","journal-title":"Leuk Res."},{"key":"2021110519402073200_B9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fninf.2016.00038","article-title":"pypet: a python toolkit for data management of parameter explorations","volume":"10","author":"Meyer","year":"2016","journal-title":"Front Neuroinform."},{"key":"2021110519402073200_B10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","article-title":"Machine learning applications in cancer prognosis and prediction","volume":"13","author":"Kourou","year":"2014","journal-title":"Comput Struct Biotechnol J."},{"issue":"10","key":"2021110519402073200_B11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","article-title":"Explainable machine-learning predictions for the prevention of hypoxaemia during surgery","volume":"2","author":"Lundberg","year":"2018","journal-title":"Nat Biomed Eng."},{"key":"2021110519402073200_B12","first-page":"3146","author":"Ke"},{"key":"2021110519402073200_B13","first-page":"4765","author":"Lundberg"},{"issue":"8","key":"2021110519402073200_B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/1541-7786.MCR-12-0695","article-title":"The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome","volume":"11","author":"Larsson","year":"2013","journal-title":"Mol Cancer Res."},{"issue":"1","key":"2021110519402073200_B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.12515","article-title":"The molecular pathogenesis of the myelodysplastic syndromes","volume":"95","author":"Pellagatti","year":"2015","journal-title":"Eur J Haematol."},{"issue":"4","key":"2021110519402073200_B16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3324\/haematol.2012.071449","article-title":"Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes","volume":"98","author":"Senent","year":"2013","journal-title":"Haematologica."},{"issue":"2","key":"2021110519402073200_B17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.2020004850","article-title":"SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS","volume":"136","author":"Malcovati","year":"2020","journal-title":"Blood."},{"key":"2021110519402073200_B18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2019.06.014","article-title":"A decision-tree approach for the differential diagnosis of chronic lymphoid leukemias and peripheral B-cell lymphomas","volume":"178","author":"Moraes","year":"2019","journal-title":"Comput Methods Programs Biomed."},{"issue":"2","key":"2021110519402073200_B19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOH.0000000000000400","article-title":"Therapeutic choices after hypomethylating agent resistance for myelodysplastic syndromes","volume":"25","author":"Montalban-Bravo","year":"2018","journal-title":"Curr Opin Hematol."},{"issue":"3","key":"2021110519402073200_B20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10238-020-00641-4","article-title":"Role of TP53 mutations in predicting the clinical efficacy of hypomethylating therapy in patients with myelodysplastic syndrome and related neoplasms: a systematic review and meta-analysis","volume":"20","author":"Cai","year":"2020","journal-title":"Clin Exp Med."},{"issue":"9","key":"2021110519402073200_B21","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1182\/blood-2011-08-375758","article-title":"TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome","volume":"119","author":"R\u00fccker","year":"2012","journal-title":"Blood."},{"issue":"7","key":"2021110519402073200_B22","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00277-020-04082-7","article-title":"Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia","volume":"99","author":"Becker","year":"2020","journal-title":"Ann Hematol."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/21\/4361\/1833378\/advancesadv2021004755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/21\/4361\/1833378\/advancesadv2021004755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T19:40:38Z","timestamp":1636141238000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/21\/4361\/477106\/A-geno-clinical-decision-model-for-the-diagnosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":22,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021,11,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004755","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]}}}